全文获取类型
收费全文 | 1508篇 |
免费 | 125篇 |
国内免费 | 1篇 |
出版年
2023年 | 4篇 |
2022年 | 10篇 |
2021年 | 23篇 |
2020年 | 12篇 |
2019年 | 28篇 |
2018年 | 24篇 |
2017年 | 19篇 |
2016年 | 38篇 |
2015年 | 60篇 |
2014年 | 66篇 |
2013年 | 83篇 |
2012年 | 116篇 |
2011年 | 133篇 |
2010年 | 63篇 |
2009年 | 54篇 |
2008年 | 95篇 |
2007年 | 99篇 |
2006年 | 90篇 |
2005年 | 105篇 |
2004年 | 83篇 |
2003年 | 77篇 |
2002年 | 83篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 12篇 |
1998年 | 24篇 |
1997年 | 16篇 |
1995年 | 15篇 |
1994年 | 17篇 |
1993年 | 15篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 16篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1973年 | 9篇 |
1971年 | 3篇 |
排序方式: 共有1634条查询结果,搜索用时 31 毫秒
991.
Sujatha Srinivasan Congzhou Liu Caroline M. Mitchell Tina L. Fiedler Katherine K. Thomas Kathy J. Agnew Jeanne M. Marrazzo David N. Fredricks 《PloS one》2010,5(4)
Background
Little is known about short-term bacterial fluctuations in the human vagina. This study used PCR to assess the variability in concentrations of key vaginal bacteria in healthy women and the immediate response to antibiotic treatment in women with bacterial vaginosis (BV).Methodology/Principal Findings
Twenty-two women assessed for BV using Amsel''s criteria were evaluated daily for 7 or 14 days, then at 2, 3 and 4 weeks, using a panel of 11 bacterium-specific quantitative PCR assays. Participants with BV were treated with 5 days of intravaginal metronidazole. Participants without BV had vaginal biotas dominated by lactobacilli, whose levels fluctuated with menses. With onset of menstruation, quantities of Lactobacillus jensenii and Lactobacillus crispatus decreased and were found to be inversely related to Gardnerella vaginalis concentrations (p<0.001). Women with BV had a variety of fastidious bacteria whose concentrations dropped below detection thresholds 1–5 days after starting metronidazole. Recurrent BV was characterized by initial profound decreases of BV-associated bacteria after treatment followed by subsequent increases at relapse.Conclusions/Significance
The microbiota of the human vagina can be highly dynamic. Healthy women are colonized with Lactobacillus species, but levels can change dramatically over a month. Marked increases in G. vaginalis were observed during menses. Participants with BV have diverse communities of fastidious bacteria that are depleted by vaginal metronidazole therapy. Women with recurrent BV initially respond to antibiotic treatment with steep declines in bacterial concentrations, but these bacteria later reemerge, suggesting that antibiotic resistance in these bacteria is not an important factor mediating BV recurrence. 相似文献992.
Roni Mamluk Irvith M Carvajal Brent A Morse Henry Wong Janette Abramowitz Sharon Aslanian Ai-Ching Lim Jochem Gokemeijer Michael J Storek Joonsoo Lee Michael Gosselin Martin C Wright Ray T Camphausen Jack Wang Yan Chen Kathy Miller Kerry Sanders Sarah Short Jeff Sperinde Gargi prasad Stephen Williams Robert Kerbel John ebos Anthony Mutsaers John D Mendlein Alan S Harris Eric S Furfine 《MABS-AUSTIN》2010,2(2):199-208
CT-322 is a new anti-angiogenic therapeutic agent based on an engineered variant of the tenth type III domain of human fibronectin, i.e., an Adnectin™, designed to inhibit vascular endothelial growth factor receptor (VEGFR)-2. This PE Gylated Adnectin was developed using an mRNA display technology. CT-322 bound human VEGFR-2 with high affinity (KD, 11 nM), but did not bind VEGFR-1 or VEGFR-3 at concentrations up to 100 nM, as determined by surface plasmon resonance studies. Western blot analysis showed that CT-322 blocked VEGF-induced phosphorylation of VEGFR-2 and mitogen-activated protein kinase in human umbilical vascular endothelial cells. CT-322 significantly inhibited the growth of human tumor xenograft models of colon carcinoma and glioblastoma at doses of 15–60 mg/kg administered 3 times/week. Anti-tumor effects of CT-322 were comparable to those of sorafenib or sunitinib, which inhibit multiple kinases, in a colon carcinoma xenograft model, although CT-322 caused less overt adverse effects than the kinase inhibitors. CT-322 also enhanced the anti-tumor activity of the chemotherapeutic agent temsirolimus in the colon carcinoma model. The high affinity and specificity of CT-322 binding to VEGFR-2 and its anti-tumor activities establish CT-322 as a promising anti-angiogenic therapeutic agent. Our results further suggest that Adnectins are an important new class of targeted biologics that can be developed as potential treatments for a wide variety of diseases.Key words: CT-322, adnectin, VEGFR-2, tumor angiogenesis, angiogenesis inhibitor, biologics, targeted therapy 相似文献
993.
Arion Kennedy Kristina Martinez Soonkyu Chung Kathy LaPoint Robin Hopkins Soren F. Schmidt Kenneth Andersen Susanne Mandrup Michael McIntosh 《Journal of lipid research》2010,51(7):1906-1917
We previously demonstrated that trans-10, cis-12 (10,12) conjugated linoleic acid (CLA) induced inflammation and insulin resistance in primary human adipocytes by activating nuclear factor κB (NFκB) and extracellular signal-related kinase (ERK) signaling. In this study, we demonstrated that the initial increase in intracellular calcium ([Ca2+]i) mediated by 10,12 CLA was attenuated by TMB-8, an inhibitor of calcium release from the endoplasmic reticulum (ER), by BAPTA, an intracellular calcium chelator, and by D609, a phospholipase C (PLC) inhibitor. Moreover, BAPTA, TMB-8, and D609 attenuated 10,12 CLA–mediated production of reactive oxygen species (ROS), activation of ERK1/2 and cJun-NH2-terminal kinase (JNK), and induction of inflammatory genes. 10,12 CLA–mediated binding of NFκB to the promoters of interleukin (IL)-8 and cyclooxygenase (COX)-2 and induction of calcium-calmodulin kinase II (CaMKII) β were attenuated by TMB-8. KN-62, a CaMKII inhibitor, also suppressed 10,12 CLA–mediated ROS production and ERK1/2 and JNK activation. Additionally, KN-62 attenuated 10,12 CLA induction of inflammatory and integrated stress response genes, increase in prostaglandin F2α, and suppression of peroxisome proliferator activated receptor γ protein levels and insulin-stimulated glucose uptake. These data suggest that 10,12 CLA increases inflammation and insulin resistance in human adipocytes, in part by increasing [Ca2+]i levels, particularly calcium from the ER. 相似文献
994.
Indu Kohaar Alexander Ploss Evgenia Korol Kathy Mu John W. Schoggins Thomas R. O'Brien Charles M. Rice Ludmila Prokunina-Olsson 《Journal of virology》2010,84(14):6987-6994
Persistent hepatitis C virus (HCV) infection is a primary etiological factor for the development of chronic liver disease, including cirrhosis and cancer. A recent study identified occludin (OCLN), an integral tight junction protein, as one of the key factors for HCV entry into cells. We explored the splicing diversity of OCLN in normal human liver and observed variable expression of alternative splice variants, including two known forms (WT-OCLN and OCLN-ex4del) and six novel forms (OCLN-ex7ext, OCLN-ex3pdel, OCLN-ex3del, OCLN-ex3-4del, OCLN-ex3p-9pdel, and OCLN-ex3p-7pdel). Recombinant protein isoforms WT-OCLN and OCLN-ex7ext, which retained the HCV-interacting MARVEL domain, were expressed on the cell membrane and were permissive for HCV infection in in vitro infectivity assays. All other forms lacked the MARVEL domain, were expressed in the cytoplasm, and were nonpermissive for HCV infection. Additionally, we observed variable expression of OCLN splicing forms across human tissues and cell lines. Our study suggests that the remarkable natural splicing diversity of OCLN might contribute to HCV tissue tropism and possibly modify the outcome of HCV infection in humans. Genetic factors crucial for regulation of OCLN expression and susceptibility to HCV infection remain to be elucidated.Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, the fifth most common malignancy worldwide, and the third leading cause of cancer-related death, after cancers of lung and stomach (WHO Mortality Database [http://www.who.int/healthinfo/morttables/en/index.html]). The estimated incidence of new HCC cases is about 500,000 to 1,000,000 annually, with mortality of 600,000 cases per year on a global scale (12, 16, 17, 20, 24). Various risk factors for HCC include infection with hepatitis C virus (HCV) or hepatitis B virus (HBV), toxic exposures (alcohol and aflatoxins), metabolic disease (diabetes, nonalcoholic fatty liver disease, and hereditary hemochromatosis), and immune-related conditions such as primary biliary cirrhosis and autoimmune hepatitis (15).The only established in vivo model for the study of HCV infection in an immunocompetent host is the chimpanzee (23). The inability of HCV to infect animals other than humans and chimpanzees has severely hampered efforts in developing a useful small animal model for the disease, specific antiviral therapies, and an effective vaccine against HCV-mediated liver cancer (18, 23).In the United States, chronic HCV infection is the major etiological agent of liver cancer. Among individuals infected with HCV, approximately 80% develop chronic HCV infection, of which 20% will progress to cirrhosis, and 1 to 5% will progress to liver cancer (14). Genetic factors might affect the risk of liver cancer by modifying the susceptibility to HCV infection and viral clearance. Recent studies identified occludin (OCLN), an integral tight junction (TJ) protein, as one of the key factors for HCV entry into cells (8, 18). HCV infectivity was exclusively mediated by the second extracellular loop (EC2) of the OCLN MARVEL membrane-associating domain (18). This domain is found in proteins involved in lipid-rich membrane apposition events, such as cell fencing contacts and formation of vesicular particles (19). OCLN also has a large intracellular protein (ELL) domain, found in C-terminal parts of OCLN and in the ELL family of RNA polymerase II elongation factors (7), but its role in HCV infection is unclear.We hypothesized that splicing diversity, generating multiple functionally distinct OCLN protein isoforms, might modulate susceptibility to HCV infection. Six splicing forms of OCLN and two distinct promoters, P1 and P2, have been described in cell lines (4, 5, 9, 10, 13). In the present study, we explored the splicing diversity of OCLN in normal human liver and observed variable expression of known and novel isoforms. Additionally, in vitro infectivity assays proved some of these forms to be nonpermissive for HCV infection. Our study suggests that naturally occurring splicing forms of OCLN might modify the outcome of HCV infection in humans. 相似文献
995.
Chromosome engineering has allowed the generation of an extensive and well-defined series of linear human X centromere-based
minichromosomes, which has been used to investigate the influence of size and structure on chromosome segregation in vertebrate
cells. A clear relationship between overall chromosome size and mitotic stability was detected, with decreasing size associated
with increasing loss rates. In chicken DT40, the lower size limit for prolonged mitotic stability is approximately 550 kb:
at 450 kb, there was a dramatic increase in chromosome loss, while structures of approximately 200 kb could not be recovered.
In human HT1080 cells, the size threshold for mitotic stability is approximately 1.6 Mb. Minichromosomes of 0.55–1.0 Mb can
be recovered, but display high loss rates. However, all minichromosomes examined exhibited more segregation errors than normal
chromosomes in HT1080 cells. This error rate increases with decreased size and correlates with reduced levels of CENP-A and
Aurora B. In mouse LA-9 and Indian muntjac FM7 cells, the size requirements for mitotic stability are much greater. In mouse,
a human 2.7-Mb minichromosome is rarely able to propagate a kinetochore and behaves acentrically. In Indian muntjac, CENP-C
associates with the human minichromosome, but the mitotic apparatus appears unable to handle its segregation. 相似文献
996.
997.
998.
Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth
Sakao S Taraseviciene-Stewart L Wood K Cool CD Voelkel NF 《American journal of physiology. Lung cellular and molecular physiology》2006,291(3):L362-L368
We have previously hypothesized that the development of severe angioproliferative pulmonary hypertension is associated with not only initial endothelial cell (EC) apoptosis followed by the emergence of apoptosis-resistant proliferating EC but also with proliferation of vascular smooth muscle cells (VSMC). We have demonstrated that EC death results in the selection of an apoptosis-resistant, proliferating, and phenotypically altered EC phenotype. We postulate here that the initial apoptosis of EC induces the release of mediators that cause VSMC proliferation. We cultured EC in an artificial capillary CellMax system designed to simulate the highly efficient functions of the human capillary system. We induced apoptosis of microvascular EC using shear stress and the combined VEGF receptor (VEGFR-1 and -2) inhibitor SU-5416. Flow cytometry for the proliferation marker bromodeoxyuridine showed that serum-free medium conditioned by apoptosed EC induced proliferation of VSMC, whereas serum-free medium conditioned by nonapoptosed EC did not. We also show that medium conditioned by apoptosed EC is characterized by increased concentrations of transforming growth factor (TGF)-beta1 and VEGF compared with medium conditioned by nonapoptosed EC and that TGF-beta1 blockade prevented the proliferation of cultured VSMC. In conclusion, EC death induced by high shear stress and VEGFR blockade leads to the production of factors, in particular TGF-beta1, that activate VSMC proliferation. 相似文献
999.
Fan X Zhang X Zhou L Keith KA Kern ER Torrence PF 《Bioorganic & medicinal chemistry letters》2006,16(12):3224-3228
Synthetic hybridization of two privileged drug scaffolds, pyrazolone on the one hand and pyrimidine nucleoside on the other, resulted in the generation of two novel 5-substituted pyrimidine nucleosides with potent in vitro antiviral activity against two representative orthopoxviruses, vaccinia virus and cowpox virus. 相似文献
1000.
Noronha G Barrett K Cao J Dneprovskaia E Fine R Gong X Gritzen C Hood J Kang X Klebansky B Li G Liao W Lohse D Mak CC McPherson A Palanki MS Pathak VP Renick J Soll R Splittgerber U Wrasidlo W Zeng B Zhao N Zhou Y 《Bioorganic & medicinal chemistry letters》2006,16(21):5546-5550
We report the discovery and preliminary SAR studies of a series of structurally novel benzotriazine core based small molecules as inhibitors of Src kinase. To the best of our knowledge, benzotriazine template based compounds have not been reported as kinase inhibitors. The 3-(2-(1-pyrrolidinyl)ethoxy)phenyl analogue (43) was identified as one of the most potent inhibitors of Src kinase. 相似文献